Litcius/Paper detail

Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment

Guowang Cheng, Zhiwen Liu, Zhao Yan, Jiaxin Wu, Zilin Li, Sijia Gao, Chunye Zheng, Shuanshuan Guo, Yue Pan, Xiaojia Chen, Guanghui Lin, Ziqi Zhou, Tongkai Chen

2024Journal of Controlled Release18 citationsDOI

Topics & Concepts

MinocyclineParkinson's diseaseCognitive impairmentMedicineDiseaseNeurosciencePharmacologyPsychologyChemistryInternal medicineAntibioticsBiochemistryParkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment | Litcius